Kontour (Xi'an) Medical Technology Co., Ltd. (SHA:688314)

SHA:688314 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	322.68	311.71	262.63	229.61	206.31	158.34
Other Revenue	10.23	10.23	12.4	10.34	6.24	5.73
Revenue	332.92	321.95	275.03	239.95	212.55	164.08
Revenue Growth (YoY)	7.90%	17.06%	14.62%	12.89%	29.54%	11.01%
Cost of Revenue	74.21	67.93	60.38	50.19	41.99	32.16
Gross Profit	258.71	254.01	214.65	189.76	170.56	131.92
Selling, General & Admin	117.54	119.76	107.33	91.58	75.18	64.55
Research & Development	25.48	23.9	17.64	18.3	16.8	16.9
Other Operating Expenses	14.01	4.64	4.42	4.03	2.77	1.57
Operating Expenses	157.08	147.96	129.38	114.11	94.71	82.96
Operating Income	101.63	106.05	85.26	75.64	75.85	48.95
Interest Expense	-2.17	-2.17	-1.89	-1.23	-0.74	-0.37
Interest & Investment Income	2.11	5.22	5.2	8.14	4.85	3.12
Currency Exchange Gain (Loss)	-0.37	-0.37	0.23	0.49	0.03	-0.56
Other Non Operating Income (Expenses)	-1.44	-1.75	-0.3	-0.2	-0.17	-0.18
EBT Excluding Unusual Items	99.75	106.98	88.5	82.85	79.82	50.97
Gain (Loss) on Sale of Investments	-14.18	-12.59	-1.86	-	-	-
Gain (Loss) on Sale of Assets	0.03	0.44	-0.06	-0	0.02	-0.02
Asset Writedown	-0.02	-1.87	-	-0.04	-0.35	-0.01
Other Unusual Items	17.82	13.04	5.18	5.66	15.9	7.28
Pretax Income	103.4	106	91.75	88.46	95.39	58.21
Income Tax Expense	15.86	18.37	17.28	14.3	14.21	7.1
Earnings From Continuing Operations	87.54	87.64	74.47	74.16	81.18	51.12
Minority Interest in Earnings	0.87	0.76	1.04	1.53	0.44	1.26
Net Income	88.4	88.4	75.51	75.69	81.63	52.38
Net Income to Common	88.4	88.4	75.51	75.69	81.63	52.38
Net Income Growth	0.60%	17.07%	-0.23%	-7.28%	55.83%	0.86%
Shares Outstanding (Basic)	81	81	81	81	73	61
Shares Outstanding (Diluted)	81	81	81	81	73	61
Shares Change (YoY)	-0.26%	-0.12%	-0.23%	11.81%	19.10%	2.55%
EPS (Basic)	1.09	1.09	0.93	0.93	1.12	0.86
EPS (Diluted)	1.09	1.09	0.93	0.93	1.12	0.86
EPS Growth	0.86%	17.20%	-	-17.07%	30.84%	-1.64%
Free Cash Flow	68.04	92.86	71	73.78	48.05	-15.15
Free Cash Flow Per Share	0.84	1.15	0.87	0.91	0.66	-0.25
Dividend Per Share	0.380	0.360	0.320	0.371	0.443	0.371
Dividend Growth	-24.00%	12.50%	-13.84%	-16.14%	19.25%	-
Gross Margin	77.71%	78.90%	78.05%	79.08%	80.25%	80.40%
Operating Margin	30.53%	32.94%	31.00%	31.52%	35.69%	29.84%
Profit Margin	26.55%	27.46%	27.46%	31.54%	38.40%	31.92%
Free Cash Flow Margin	20.44%	28.84%	25.82%	30.75%	22.61%	-9.23%
EBITDA	113.53	117.29	95.62	85.56	83.02	55.28
EBITDA Margin	34.10%	36.43%	34.77%	35.66%	39.06%	33.69%
D&A For EBITDA	11.89	11.24	10.36	9.91	7.17	6.32
EBIT	101.63	106.05	85.26	75.64	75.85	48.95
EBIT Margin	30.53%	32.94%	31.00%	31.52%	35.69%	29.84%
Effective Tax Rate	15.34%	17.33%	18.83%	16.17%	14.90%	12.19%
Revenue as Reported	332.92	321.95	275.03	239.95	212.55	164.08
Advertising Expenses	-	16.02	17.77	19.97	17.68	15.71

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.